Rational therapy of mixed dyslipidaemia in a patient with diabetes

Charles Reasner

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.

Original languageEnglish (US)
Pages (from-to)25-30
Number of pages6
JournalBritish Journal of Diabetes and Vascular Disease
Issue number1
StatePublished - Jan 1 2007


  • Atherogenic dyslipidaemia
  • Diabetes
  • Diabetic dyslipidaemia
  • Fibrates
  • Niacin
  • Statins

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Rational therapy of mixed dyslipidaemia in a patient with diabetes'. Together they form a unique fingerprint.

Cite this